Hallmarks of glycosylation in cancer
Citations Over TimeTop 1% of 2016 papers
Abstract
Aberrant glycosylation plays a fundamental role in key pathological steps of tumour development and progression. Glycans have roles in cancer cell signalling, tumour cell dissociation and invasion, cell-matrix interactions, angiogenesis, metastasis and immune modulation. Aberrant glycosylation is often cited as a 'hallmark of cancer' but is notably absent from both the original hallmarks of cancer and from the next generation of emerging hallmarks. This review discusses how glycosylation is clearly an enabling characteristic that is causally associated with the acquisition of all the hallmark capabilities. Rather than aberrant glycosylation being itself a hallmark of cancer, another perspective is that glycans play a role in every recognised cancer hallmark.
Related Papers
- → The vasohibin family: a novel family for angiogenesis regulation(2012)113 cited
- → The vasohibin family: Novel regulators of angiogenesis(2012)27 cited
- A novel in vitro angiogenesis model based on a microfluidic device(2011)
- → Angiogenesis in Cardiovascular Disease(2007)3 cited
- → A PlGF-1 Derived Peptide Inhibits Angiogenesis via HIF-1β/VEGF Pathway(2016)